AstraZeneca PLC (AZNN) - Total Liabilities

Latest as of September 2025: MX$68.48 Billion MXN ≈ $3.94 Billion USD

Based on the latest financial reports, AstraZeneca PLC (AZNN) has total liabilities worth MX$68.48 Billion MXN (≈ $3.94 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See AZNN total equity for net asset value and shareholders' equity analysis.

AstraZeneca PLC - Total Liabilities Trend (2014–2024)

This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. For the full company profile including market capitalisation, see market cap of AstraZeneca PLC.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Industrial and Commercial Bank of China Ltd SHG:601398	China	CN¥48.85 Trillion
GE Aerospace NYSE:GE	USA	$111.27 Billion
AstraZeneca PLC NASDAQ:AZN	USA	$65.36 Billion
Morgan Stanley SA:MSBR34	Brazil	R$1.25 Trillion
General Electric Company SA:GEOO34	Brazil	R$111.49 Billion
Novartis AG MX:NVSN	Mexico	MX$64.40 Billion
Lam Research Corp NASDAQ:LRCX	USA	$11.25 Billion
Contemporary Amperex Technology Co Ltd Class A SHE:300750	China	CN¥603.80 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check asset resilience ratio of AstraZeneca PLC to evaluate the company's liquid asset resilience ratio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (2014–2024)

The table below shows the annual total liabilities of AstraZeneca PLC from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	MX$63.16 Billion ≈ $3.64 Billion	+1.95%
2023-12-31	MX$61.95 Billion ≈ $3.57 Billion	+4.25%
2022-12-31	MX$59.42 Billion ≈ $3.42 Billion	-10.07%
2021-12-31	MX$66.08 Billion ≈ $3.80 Billion	+29.33%
2020-12-31	MX$51.09 Billion ≈ $2.94 Billion	+9.21%
2019-12-31	MX$46.78 Billion ≈ $2.69 Billion	+0.37%
2018-12-31	MX$46.61 Billion ≈ $2.68 Billion	-0.22%
2017-12-31	MX$46.71 Billion ≈ $2.69 Billion	+1.86%
2016-12-31	MX$45.86 Billion ≈ $2.64 Billion	+10.37%
2015-12-31	MX$41.55 Billion ≈ $2.39 Billion	+6.67%
2014-12-31	MX$38.95 Billion ≈ $2.24 Billion	--

About AstraZeneca PLC

MX:AZNN Mexico Drug Manufacturers - General

Market Cap

$290.50 Billion

MX$5.05 Trillion MXN

Market Cap Rank

#53 Global

#1 in Mexico

Share Price

MX$1628.00

Change (1 day)

+1.25%

52-Week Range

MX$1285.00 - MX$1722.60

All Time High

MX$1751.39